Publications by authors named "G Veronesi"
System-level decisions around the commissioning and provision of healthcare services in England have contributed to barriers in accessing the National Health Service. In this article, we ask how to better regulate resource allocation to ensure greater equity in access to healthcare services. First, we focus on the Health and Care Act 2022, which, drawing on principles of deliberative regulation to address health inequalities, initiates a shift away from previous regulatory approaches towards a collaborative decision-making model.
View Article and Find Full Text PDFArticle Synopsis
- - Melanoma cases are on the rise, leading to frequent updates in guidelines for diagnosis, staging, and treatment; recent approvals now include adjuvant therapy for stage IIb/c melanoma.
- - A study involving 92 melanoma patients revealed that those with stage IIb/c have a later age of diagnosis and a higher occurrence of specific characteristics like ulceration and angiotropism compared to stage IIIa patients.
- - While not statistically significant, stage IIb/c patients showed a higher rate of metastasis over a 5-year period (15%) compared to those with stage IIIa melanoma (4%), highlighting the potential benefits of adjuvant immunotherapy for stage IIb/c patients.
Background: About one-third of workers identify organisational factors as contributors to workplace violence (WPV), but the associations between these factors and WPV have primarily been explored retrospectively and with measures of perceived organisational constraints, hence providing limited information for prevention. Therefore, we assessed whether objectively measured ward-level indicators of turnover, downsizing, overtime, and night shifts are associated with the occurrence of WPV and whether these associations vary by ward type.
Methods: We conducted an ecological study at a university hospital in northern Italy from 2016 to 2022, using wards as statistical unit (average: 230 wards per year).
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer.
Pigment Cell Melanoma Res
January 2025
Cutaneous melanoma (CM) and pancreatic cancer are aggressive tumors whose incidences are rapidly increasing in the last years. This review aims to provide a complete and update description about mutational landscape in CM and pancreatic cancer, focusing on similarities of these two apparently so different tumors in terms of site, type of cell involved, and embryonic origin. The familial forms of CM and pancreatic cancers are often characterized by a common mutated gene, namely CDKN2A.
View Article and Find Full Text PDF